,title,source,link,date
0,"Lupin, Amman Pharma collaborates for exclusive marketing of Ranibizumab",Business Standard,news.google.com/articles/CBMiiwFodHRwczovL3d3dy5idXNpbmVzcy1zdGFuZGFyZC5jb20vY29tcGFuaWVzL25ld3MvbHVwaW4tYW1tYW4tcGhhcm1hLWNvbGxhYm9yYXRlcy1mb3ItZXhjbHVzaXZlLW1hcmtldGluZy1vZi1yYW5pYml6dW1hYi0xMjMxMTEwMDA1MTFfMS5odG1s0gGPAWh0dHBzOi8vd3d3LmJ1c2luZXNzLXN0YW5kYXJkLmNvbS9hbXAvY29tcGFuaWVzL25ld3MvbHVwaW4tYW1tYW4tcGhhcm1hLWNvbGxhYm9yYXRlcy1mb3ItZXhjbHVzaXZlLW1hcmtldGluZy1vZi1yYW5pYml6dW1hYi0xMjMxMTEwMDA1MTFfMS5odG1s?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
4,"Lupin, Amman Pharma join hands to launch ophthalmic drug in West Asian market",BusinessLine,news.google.com/articles/CBMijQFodHRwczovL3d3dy50aGVoaW5kdWJ1c2luZXNzbGluZS5jb20vbWFya2V0cy9sdXBpbi1hbW1hbi1waGFybWEtam9pbi1oYW5kcy10by1sYXVuY2gtb3BodGhhbG1pYy1kcnVnLWluLXdlc3QtYXNpYW4tbWFya2V0L2FydGljbGU2NzUyMDMxNC5lY2XSAZIBaHR0cHM6Ly93d3cudGhlaGluZHVidXNpbmVzc2xpbmUuY29tL21hcmtldHMvbHVwaW4tYW1tYW4tcGhhcm1hLWpvaW4taGFuZHMtdG8tbGF1bmNoLW9waHRoYWxtaWMtZHJ1Zy1pbi13ZXN0LWFzaWFuLW1hcmtldC9hcnRpY2xlNjc1MjAzMTQuZWNlL2FtcC8?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
5,"Lupin, Amman Pharma ink pact for exclusive marketing of drug used in treatment of eye problems",CNBCTV18,news.google.com/articles/CBMilgFodHRwczovL3d3dy5jbmJjdHYxOC5jb20vYnVzaW5lc3MvY29tcGFuaWVzL2x1cGluLWFtbWFuLXBoYXJtYS1pbmstcGFjdC1mb3ItZXhjbHVzaXZlLW1hcmtldGluZy1vZi1kcnVnLXVzZWQtaW4tdHJlYXRtZW50LW9mLWV5ZS1wcm9ibGVtcy0xODI5NzMwMS5odG3SAZoBaHR0cHM6Ly93d3cuY25iY3R2MTguY29tL2J1c2luZXNzL2NvbXBhbmllcy9sdXBpbi1hbW1hbi1waGFybWEtaW5rLXBhY3QtZm9yLWV4Y2x1c2l2ZS1tYXJrZXRpbmctb2YtZHJ1Zy11c2VkLWluLXRyZWF0bWVudC1vZi1leWUtcHJvYmxlbXMtMTgyOTczMDEuaHRtL2FtcA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
7,Is Lupin (NSE:LUPIN) Using Too Much Debt?,Simply Wall St,news.google.com/articles/CBMie2h0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvaW4vcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbnNlLWx1cGluL2x1cGluLXNoYXJlcy9uZXdzL2lzLWx1cGluLW5zZWx1cGluLXVzaW5nLXRvby1tdWNoLWRlYnQtMdIBf2h0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvaW4vcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbnNlLWx1cGluL2x1cGluLXNoYXJlcy9uZXdzL2lzLWx1cGluLW5zZWx1cGluLXVzaW5nLXRvby1tdWNoLWRlYnQtMS9hbXA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
8,Lupin And Amman Pharma Sign Exclusive Licensing And Supply Agreement For Ranibizumab Biosimilar,Free Press Journal,news.google.com/articles/CBMiiAFodHRwczovL3d3dy5mcmVlcHJlc3Nqb3VybmFsLmluL2J1c2luZXNzL2x1cGluLWFuZC1hbW1hbi1waGFybWEtc2lnbi1leGNsdXNpdmUtbGljZW5zaW5nLWFuZC1zdXBwbHktYWdyZWVtZW50LWZvci1yYW5pYml6dW1hYi1iaW9zaW1pbGFy0gGMAWh0dHBzOi8vd3d3LmZyZWVwcmVzc2pvdXJuYWwuaW4vYW1wL2J1c2luZXNzL2x1cGluLWFuZC1hbW1hbi1waGFybWEtc2lnbi1leGNsdXNpdmUtbGljZW5zaW5nLWFuZC1zdXBwbHktYWdyZWVtZW50LWZvci1yYW5pYml6dW1hYi1iaW9zaW1pbGFy?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
24,Balsalazide Industry is Booming Globally by 2030 | Salix ...,Argyle Report,news.google.com/articles/CBMiigFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL25ld3MvYmFsc2FsYXppZGUtaW5kdXN0cnktaXMtYm9vbWluZy1nbG9iYWxseS1ieS0yMDMwLXNhbGl4LXBoYXJtYWNldXRpY2Fsc2JhdXNjaC1oZWFsdGgtYW50ZXItYXBvdGV4LzM2NjgwNS_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
10,Lupin and Amman Pharma Sign Exclusive Licensing and Supply ...,Lupin,news.google.com/articles/CBMidmh0dHBzOi8vd3d3Lmx1cGluLmNvbS9sdXBpbi1hbmQtYW1tYW4tcGhhcm1hLXNpZ24tZXhjbHVzaXZlLWxpY2Vuc2luZy1hbmQtc3VwcGx5LWFncmVlbWVudC1mb3ItcmFuaWJpenVtYWItYmlvc2ltaWxhci_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
1,Lupin hit 52-week high as investors cheer stellar Q2 earnings,Moneycontrol,news.google.com/articles/CBMifmh0dHBzOi8vd3d3Lm1vbmV5Y29udHJvbC5jb20vbmV3cy9idXNpbmVzcy9tYXJrZXRzL2x1cGluLWhpdC01Mi13ZWVrLWhpZ2gtYXMtaW52ZXN0b3JzLWNoZWVyLXN0ZWxsYXItcTItZWFybmluZ3MtMTE3MDMzMzEuaHRtbNIBggFodHRwczovL3d3dy5tb25leWNvbnRyb2wuY29tL25ld3MvYnVzaW5lc3MvbWFya2V0cy9sdXBpbi1oaXQtNTItd2Vlay1oaWdoLWFzLWludmVzdG9ycy1jaGVlci1zdGVsbGFyLXEyLWVhcm5pbmdzLTExNzAzMzMxLmh0bWwvYW1w?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
63,Culprits: Is Gemma Arterton's Lupin-style show worth watching?,Digital Spy,news.google.com/articles/CBMiR2h0dHBzOi8vd3d3LmRpZ2l0YWxzcHkuY29tL3R2L2E0NTc2NTIzNS9jdWxwcml0cy1nZW1tYS1hcnRlcnRvbi1yZXZpZXcv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
35,"Active Pharmaceutical Ingredients CDMO Market worth $229.39 billion by 2030, growing at a CAGR of 10.32% - Exc",openPR,news.google.com/articles/CBMiXmh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjgyMTg0L2FjdGl2ZS1waGFybWFjZXV0aWNhbC1pbmdyZWRpZW50cy1jZG1vLW1hcmtldC13b3J0aC0yMjktMznSAV1odHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMjgyMTg0L2FjdGl2ZS1waGFybWFjZXV0aWNhbC1pbmdyZWRpZW50cy1jZG1vLW1hcmtldC13b3J0aC0yMjktMzk?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
